The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
82373662 8237366 2 F 20110626 20160823 20111109 20160919 EXP US-ROCHE-798074 ROCHE 71.70 YR M Y 66.40000 KG 20160919 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
82373662 8237366 1 PS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) LAST DOSE:14 JUN 2011, IV OVER 30-90 MINUTES ON DAY 1. 125085 15 MG/KG SOLUTION FOR INFUSION
82373662 8237366 2 SS LENALIDOMIDE LENALIDOMIDE 1 Oral QD, ON DAYS 1-14. LAST DOSE PRIOR TO SAE ON 27 JUN 2011. 0
82373662 8237366 3 SS LENALIDOMIDE LENALIDOMIDE 1 Oral DELAYED FOR 7 DAYS. TOTAL DOSE 275 MG 0
82373662 8237366 4 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) OVER 60 MINUTES ON DAY 1. LAST DOSE PRIOR TO SAE ON 14 JUN 2011. 0 125 MG
82373662 8237366 5 SS PREDNISONE. PREDNISONE 1 Oral LAST DOSE 11/JUL/2011 0 BID
82373662 8237366 6 SS PREDNISONE. PREDNISONE 1 Oral TOTAL DOSE 27.5 MG, DELAYED 7 DAYS 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
82373662 8237366 1 Prostate cancer metastatic
82373662 8237366 2 Prostate cancer metastatic
82373662 8237366 4 Prostate cancer metastatic
82373662 8237366 5 Prostate cancer metastatic

Outcome of event

Event ID CASEID OUTC COD
82373662 8237366 LT
82373662 8237366 HO
82373662 8237366 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
82373662 8237366 Acute kidney injury
82373662 8237366 Anaemia
82373662 8237366 Blood creatinine increased
82373662 8237366 Haematuria
82373662 8237366 Hypoalbuminaemia
82373662 8237366 Neutrophil count decreased
82373662 8237366 Sepsis
82373662 8237366 Urinary tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
82373662 8237366 4 20100712 0
82373662 8237366 5 20100712 0
82373662 8237366 6 20110722 0